Showing results (91-100 of 187) with videos related to

Sort By:
Pageof 19
Molecular Cancer Therapeutics|December 10, 2009
Abcc2 (Mrp2), Abcc3 (Mrp3), and Abcg2 (Bcrp1) are the main determinants for rapid elimination of methotrexate and its toxic metabolite 7-hydroxymethotrexate in vivoMaria L H Vlaming, Anita van Esch, Zeliha Pala, et al.
Frontiers in Medicine|June 1, 2023
Crosstalk between TLR8 and RIG-I-like receptors enhances antiviral immune responsesKillian E Vlaming, Kelly van Wijnbergen, Tanja M Kaptein, et al.
The Journal of Pathology|June 10, 2025
Post-COVID-19 condition: clinical phenotypes, pathophysiological mechanisms, pathology, and management strategiesLarissa E Vlaming-van Eijk, Guolu Tang, Arno R Bourgonje, et al.
Frontiers in Immunology|November 7, 2022
Tumor infiltrating CD8/CD103/TIM-3-expressing lymphocytes in epithelial ovarian cancer co-express CXCL13 and associate with improved survivalMartijn Vlaming, Vrouyr Bilemjian, Jimena Álvarez Freile, et al.
The American Journal of Case Reports|June 28, 2018
Pediatric Condition Falsification Misdiagnosed by Misjudged Weight Growth from the Curve of Measured WeightsMartin J C van Gemert, Marianne Vlaming, Eric Osinga, et al.
Environmental Pollution (Barking, Essex : 1987)|May 22, 2003
Integrated assessment of the impacts of agricultural drainwater in the Salinas River (California, USA)B S Anderson, J W Hunt, B M Phillips, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 21, 2015
Generation of Bayesian prediction models for OATP-mediated drug-drug interactions based on inhibition screen of OATP1B1, OATP1B1∗15 and OATP1B3E van de Steeg, J Venhorst, H T Jansen, et al.
Frontiers in Genetics|November 25, 2022
DOT1L inhibition does not modify the sensitivity of cutaneous T cell lymphoma to pan-HDAC inhibitors <i>in vitro</i>Eliza Mari Kwesi-Maliepaard, Muddassir Malik, Tibor van Welsem, et al.
Communications Biology|October 13, 2021
Multivariate analysis reveals shared genetic architecture of brain morphology and human behaviorRonald de Vlaming, Eric A W Slob, Philip R Jansen, et al.
Frontiers in Immunology|August 7, 2023
EGFR-selective activation of CD27 co-stimulatory signaling by a bispecific antibody enhances anti-tumor activity of T cellsVinicio Melo, Levi Collin Nelemans, Martijn Vlaming, et al.
Pageof 19